Patent ID: 11905516
Assignee: INSTITUT PASTEUR
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  Y | IPC A  C

Claim 11:
12. The engineered bacteriophage or packaged phagemid according to claim 1, wherein the bacteriophage is selected from the group consisting of IKe, CTX-φ, Pf1, Pf2, Pf3, Myoviridae; Siphoviridae; Podoviridae; Tectiviridae; Corticoviridae; Lipothrixviridae; Plasmaviridae; Rudiviridae; Fuselloviridae; Inoviridae; Microviridae; Leviviridae, Cystoviridae, coliphages, B 1, ATCC 51477-B1, B40-8, Bf-1, phiHSCO1, phiHSC02, phiC2, phiC5, phiC6, phiC8, phiCD119, phiCD27, KP01K2, K11, Kpn5, KP34, JDOO1, phiNMl, 80alpha, IME-EF1, ENB6, C33, phiKMV, PAK-P1, LKD16, LKA1, delta, sigma-1, J-1, T2, T4, T5, T7, RB49, phiX174, R17, and PRD1 bacteriophages, or the phagemid is packaged into the capsid of one of these bacteriophages.